MUMBAI, 24 September 2026 — Moneyview Limited is scheduled to begin IPO bidding today at ₹32–₹34 per share. NSE’s issue-detail record sets September 28 as the closing date and specifies a 441-share minimum order quantity. The opening had not taken place when this pre-market report was prepared.
Verified details
| Company | Moneyview Limited |
|---|---|
| Application window | 24-Sep-2026 to 28-Sep-2026 |
| Price band | Rs. 32 to Rs. 34 per Equity Share |
| Quoted lot unit | 441 Equity Shares and in multiples thereof |
| Registrar | MUFG Intime India Private Limited |
What the lot costs
Multiplying the 441-share lot by the band gives ₹14,112 at ₹32 and ₹14,994 at ₹34. These are application-value calculations, not expected proceeds or an estimate of fair value. The eventual issue price and allocation determine the final share cost for a successful applicant.
Zero fields before opening are not weak demand
The current-issue record marks MONEYVIEW Active but shows zero in both the shares-offered demand field and bid field. Its issuer-detail page has no demand update timestamp. A ratio with no populated denominator cannot measure subscription, so there is no opening subscription multiple to report yet. This article does not interpret those placeholders as investor rejection.
Mandate and registrar checks
NSE gives September 28 at 5 p.m. as the UPI mandate-confirmation deadline and lists MUFG Intime India Private Limited as registrar. Applications need the required payment confirmation; placing an order alone is not proof of acceptance. Broker cut-offs may be earlier, so applicants should verify their intermediary’s operational timetable. The prospectus remains the reference for financial risks, allocations and offer structure.
Source check: CapKet retrieved the linked exchange records at approximately 00:57 IST on 24 September 2026. Event dates and source update times are distinguished from this publication date. Later corrections may change the official record.
Disclosure: AI-assisted, independently written reporting from attributed public records; no independent human review is claimed. This is general information, not an investment recommendation. No listing return, dividend receipt or buyback acceptance is guaranteed.